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Abstract
Many prion-forming proteins contain glutamine/asparagine (Q/N) rich domains, and there
are conflicting opinions as to the role of primary sequence in their conversion to the prion
form: is this phenomenon driven primarily by amino acid composition, or, as a recent compu-
tational analysis suggested, dependent on the presence of short sequence elements with
high amyloid-forming potential. The argument for the importance of short sequence ele-
ments hinged on the relatively-high accuracy obtained using a method that utilizes a collec-
tion of length-six sequence elements with known amyloid-forming potential. We weigh in on
this question and demonstrate that when those sequence elements are permuted, even
higher accuracy is obtained; we also propose a novel multiple-instance machine learning
method that uses sequence composition alone, and achieves better accuracy than all exist-
ing prion prediction approaches. While we expect there to be elements of primary sequence
that affect the process, our experiments suggest that sequence composition alone is suffi-
cient for predicting protein sequences that are likely to form prions. A web-server for the pro-
posed method is available at http://faculty.pieas.edu.pk/fayyaz/prank.html, and the code for
reproducing our experiments is available at http://doi.org/10.5281/zenodo.167136.
Author summary
The determinants of prion formation in proteins that are rich in glutamine and asparagine
are still under debate: is the process driven by primary sequence or by amino acid compo-
sition? In 2015 Sabate et al. published a paper suggesting that the process is triggered by
short amyloid-prone sequences. Their argument was based on the success of their
pWALTZ classifier, which uses a database of short peptides with known amyloid forming
propensities. To explore the validity of their argument we compared their original scoring
matrices with shuffled scoring matrices, and found no decrease in accuracy, suggesting
that the success of pWALTZ is the result of the ability of the scoring matrices to capture
amino acid composition. Furthermore, we propose a novel machine learning approach
with accuracy that is superior to all published prion prediction methods that are currently
available, and uses sequence composition alone.
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Introduction
Prion-forming proteins can exist in multiple structural states; in their prion state they form
amyloid aggregates that are transmissible/infectious and are the cause of several diseases [1].
In mammals, conversion of the prion protein PrPSc to an amyloid form is toxic to cells and
results in lethal neurodegenerative diseases like Creutzfeldt-Jacob disease, bovine spongiform
encephalopathy, and kuru [2]. Furthermore, a number of recent papers have suggested that
several common chronic disorders such as Alzheimer’s and Parkinson’s diseases as well as
amyotrophic lateral sclerosis exhibit prion-like characteristics [3–5]. However, not all prions
are harmful; in fact, it has been suggested that some prions may give selective advantage to
individuals expressing these traits in certain environmental conditions [6].
Due to their unusual mode of inheritance and pathological significance, the study of prions
is a very active area of research. Much of the research has been in the yeast S. cerevisiae, where
prion-forming proteins are predominantly Q/N rich [7]. As the assays for confirming the
prion activity of a protein are time consuming and very challenging to perform on a genome-
wide scale, the development of methods for pre-screeing proteins for this function is an impor-
tant task that can contribute to prion research in two major ways. First, such techniques can
allow discovery of new prions and identification of their prion domains. A prion domain is the
region within a prion protein that is essential for the protein to switch to a stable, heritable
prion conformation [8, 9]. Second, such techniques can help identify the compositional,
sequence, physiochemical or structural characteristics that are important for prion formation.
In the research community there is no agreement on the primary forces that drive prion for-
mation: whether it is guided mainly by amino-acid composition [9, 10], or as recent computa-
tional work suggests, that short sequences within Q/N rich disordered regions drive prion
formation [11–13]. In what follows we present the experimental and computational findings
related to this question.
The first two prion proteins discovered, Ure2 and Sup35 [14], both contain a Q/N-rich
domain that is critical for prion activity [15–17], and scrambling the order of the amino acids
in these prion domains does not inhibit prion formation [9, 10], highlighting a critical role for
amino acid composition in driving prion activity. Various labs have developed methods to
experimentally identify new prions based on amino acid composition. Early attempts focused
primarily on identifying protein segments with high Q/N content [18–20]; these efforts con-
tributed to the discovery of the prion protein Rnq1 [20] and the candidate prion New1 [21].
The first systematic study aimed at testing whether similarity in sequence composition is suffi-
cient for distinguishing between prion and non-prion domains was performed by Alberti et al.
[7]. They conducted a targeted proteome-wide search for promising prion candidates in S. cer-
evisiae using a Hidden Markov Model (HMM) trained on four known yeast prions. They then
used four different assays to experimentally test the prionogenicity of the 100 top scoring pro-
tein domains. Out of these, a total of 18 domains were found to exhibit prion-like behavior in
all four assays, while an additional 18 failed to show prion-like activity in any of the four assays.
The availability of this experimental data opened the doors for development of more accurate
methods for prediction of prion activity and understanding the nature of prion formation.
Further experimental and computational work that supported the hypothesis that prion for-
mation is primarily determined by sequence composition was performed by Toombs et al.
[22]. They developed an in vivo method to quantitatively determine the prion propensity for
each amino acid using a library of Sup35 mutants, and used these propensities as the basis for
an algorithm called PAPA that predicts the prion-forming potential of a protein [23]. They
demonstrated that PAPA, which uses sequence composition alone, is very effective at predict-
ing prion activity in the dataset created by Alberti et al. [7]. Other work in this area such as
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that by Angarica et al. [24] and the Michelitsh-Weissman (MW) score [25] are also in agree-
ment with these findings.
Recently several proteins with prion forming domains have been discovered in species
other than yeast and human as a result of searches using PAPA and other methods. These
include the bacterium Clostridium botulinum [26], Arabidopsis [27], and the fruit fly [28]. This
suggests that prions are more prevalent than previously thought, and highlights the impor-
tance of accurate methods for identifying proteins with prion forming domains.
The recent model by Sabate et al. suggests that the presence of specific short amyloid-prone
sequences that occur within intrinsically disordered Q/N rich regions are responsible for prion
formation [13]. They measure the tendency of a Q/N rich region to be structurally disordered
using the FoldIndex method and then score its propensity to form amyloids using WALTZ
[29, 30]. For this purpose, WALTZ employs a position-specific scoring matrix (PSSM) devel-
oped from the amyloid properties of a set of hexapeptides. The resulting method, named
pWALTZ, provides high accuracy for distinguishing between prions and non-prions from the
Alberti dataset. Based on these results, Sabate et al. concluded that prion formation in Q/N
rich yeast prions is predominantly driven by short sequence elements rather than its sequence
composition.
The work presented here is a further discussion of the question of the extent to which pri-
mary sequence elements contribute to prion formation. We performed several computational
experiments that provide support for the hypothesis that sequence composition is the primary
driving force behind prion formation. First, we considered the argument of Sabate et al. that
the high accuracy of pWALTZ suggests a role of primary sequence. In order to test this argu-
ment, we used scrambled PSSMs instead of those used in pWALTZ, and found no reduction in
classification accuracy. Furthermore, we present a supervised machine learning algorithm
called prion RANKing and classification (pRANK) that uses sequence composition alone, and
has improved performance compared to all existing methods in predicting prionogenenicity of
a protein sequence and localizaing its most prion-like domain. One of the major challenges in
developing such a classifier is that the prion forming domain in a prion protein may either be
unknown or its annotation may cover an area larger than the minimal set of amino acids
required for prion formation. pRANK addresses this challenge through the use of multiple-
instance learning (MIL) [31]. We demonstrate that multiple-instance learning allows us to
model prion domain localization and classification very accurately using yeast and human
data. Finally, we report results of in silico mutagenesis of non-prion sequences to increase prion
activity and their correspondence with experimental findings published by Paul et al [32].
Results and discussion
In this work we compare several methods designed for the prediction of protein priogenicity,
i.e., whether a protein contains a prion forming domain, and demonstrate the effectiveness of
using sequence composition alone for this task.
Amino acid composition is the primary feature that predicts prion activity
Based on the accuracy of their pWALTZ prion prediction method, Sabate et al. have recently
suggested a model of prion formation that depends on the presence of specific short sequence
elements with high amyloid propensity [11]. On the basis of pWALTZ, which is designed to
identify prions in Q/N rich proteins, the same group created PrionW—a web-server for the
purpose of identifying prion-forming proteins at a genome-wide scale; PrionW first identifies
proteins with disordered and Q/N rich regions, and proteins that pass these requirements are
then scored by the pWALTZ scoring function [13]. The pWALTZ scoring function uses a
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Position Specific Scoring Matrix (PSSM) constructed from sequence with known amyloid pro-
pensity along with other features such as physiochemical properties and features based on
structural modeling. In this work we investigate the contribution of primary sequence to the
accuracy of pWALTZ/PrionW.
The PrionW PSSM is computed from hexapeptides with known amyloid potential. If short
peptide sequence elements drive prion formation, then scrambling the PSSM with respect to
position should reduce the accuracy of prion prediction (note that this form of scrambling is
equivalent to scrambling the columns of the underlying multiple sequence alignment used to
construct the PSSM). To test this, we generated all 720 possible permutations of the six col-
umns in the scoring matrix and computed the average PSSM score across all permutations.
We compared our implementation of pWALTZ-like scoring with PSSM features and its
scrambled counterparts on two datasets. The first is a subset of the Q/N rich proteins tested by
Alberti for which their assays indicated a clear distinction between prion-forming and non
prion-forming domains [7]; the second dataset is designed to test the ability to detect prion
forming proteins at a proteome-wide scale and consists of the Alberti proteins that are clear
prion-forming as well as a non-redundant set of yeast proteins containing 5,575 sequences.
Full details of the dataset are provided in the Methods section. If prions and non-prions can be
distinguished due to primary-sequence properties rather than amino acid composition, scram-
bling the profile matrix in pWALTZ would result in a reduction of prediction accuracy. How-
ever, no decrease in performance is observed as shown in Table 1 for either of the two datasets.
Similar results were obtained in two additional scrambling experiments. In the first, we scram-
bled the hexamers before forming the PSSM, again averaging over multiple permutations. In
the second, we scrambled the prion domain, and scored it with the original PSSM. In both
cases no decrease in accuracy over the orignal PSSM is observed (see Table 1). Finally, as
shown next, we are able to predict prions with even higher accuracy using only amino acid
composition features using a machine learning algorithm specifically designed to model
prion-forming sequences.
Prion prediction with pRANK
One of the challenges in applying supervised learning to the problem of predicting protein
priogenicity is that the labeled data—annotations of prion domains within a prion-forming
protein—have inaccuracies that are the result of the difficulty of exact delineation of that
domain. To address the uncertainty in the annotated prion domain we developed a method
called prion RANKing and classification (pRANK) using the technique of multiple-instance
learning (MIL), which allows to explicitly model this uncertainty [33, 34].
Table 1. Accuracy of several variants of pWALTZ-like scoring. The method described as “original PSSM” uses the pWALTZ PSSM; “scrambled PSSM”
averages over all permutations of the positions of the PSSM; “scrambled hexamers” first scrambles the hexamers from which the PSSM is constructed;
“scrambled prion domain” tests the ability of the original PSSM to detect scrambled versions of the prion domain. Accuracy is measured using the area under
the receiver operating characteristic curve (AUC-ROC) and the area under the precision recall curve (AUC-PR). All methods use a filtering step that considers
only regions with negative FoldIndex scores and Q/N content of at least 25%. Figure A in S1 File provides the ROC and PR curves corresponding to these
results, and Table A in S1 File provides additional results when no pre-filtering is performed.
pWALTZ-like method Alberti dataset Yeast proteome
AUC-ROC AUC-PR AUC-ROC AUC-PR
original PSSM 87.4 91.3 96.4 12.3
scrambled PSSM 90.9 93.9 96.8 32.2
scrambled hexamers 88.4 92.0 96.6 22.4
scrambled prion domain 89.4 94.1 96.6 15.4
https://doi.org/10.1371/journal.pcbi.1005465.t001
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In what follows we compare various flavors of pRANK that use both position-dependent
and position independent representations with the performance of several other methods: the
HMM classifier of Alberti et al. [7], PAPA, and pWALTZ (Table 2). For this comparison, we
have used the webserver implementation of pWALTZ called PrionW [13]. pRANK outper-
forms all other approaches in prion prediction, achieving a very high AUC-ROC score of
96.8% with PAPA is close second. Both methods use only amino acid composition, further evi-
dence for the role of amino acid composition in prion formation.
In order to further explore the impact of primary sequence on prion prediction, we also
experimented with a position dependent amino acid composition feature representation,
which models a protein sequence as a vector of position-specific indicator variables. pRANK
with position-dependent amino acid composition had an AUC-ROC score of 86.8%, much
lower than the position-independent version. This low score provides further indirect evidence
of the limited impact of primary sequence on prediction of prion domains.
Finally, we compared pRANK with the method of Angarica et al [24]. Angarica et al. report
an AUC-ROC of 85% using a bootstrap performance evaluation protocol. Using the same
bootstrap protocol, pRANK yielded an AUC-ROC of 92.30%.
Localization of prion domains
pRANK can also predict the most prion-like domain within a protein by scoring each
sequence window in a given protein. Our resuls show that pRANK provides very high accuracy
for prion domain localization as well: the top pRANK prediction is always within the anno-
tated prion domain for all proteins in our data set. For PAPA and prionW this is the case in
only 86.4% and 72.7% of proteins, respectively.
The role of multiple instance learning
To understand the improved performance of pRANK we need to understand the concept of
MIL. In MIL, examples come in bags: positive and negative [33]. In our application an example
is a window within a protein sequence; in a positive bag, a prion forming domain in this case,
we assume that at least one sequence window in the bag is indeed positive; in a negative bag all
examples are negative (see Fig 1). This is a weaker form of labeling positive examples, and cap-
tures the scenario in this classification problem very well, where not all of the sequence win-
dows within an annotated prion domain are prionogenic. This allows the classifier to
essentially ignore the windows that do not represent the target concept well. We have recently
presented a novel formulation of MIL and demonstrated its advantage in detection of Calmod-
ulin binding domains over several baseline approaches including standard multiple instance
Table 2. Classifier performance on the Alberti dataset. Performance is measured with leave-one-protein-
out cross-validation using the area under the ROC curve (AUC-ROC) and the area under the precision recall
curve (AUC-PR); the curves are provided in Figure B in S1 File.
Classifier AUC-ROC AUC-PR
pRANK 96.8 96.8
miSVM 92.2 90.4
SVM 87.4 87.8
Random Forests 88.0 90.6
PAPA 95.1 96.8
PrionW 86.7 89.8
PLAAC 68.7 74.7
https://doi.org/10.1371/journal.pcbi.1005465.t002
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learning [34]. In this work we apply the same MIL formulation and present an improved train-
ing algorithm (see details in the Methods section).
To demonstrate the advantage of our MIL formulation, Table 2 compares the performance
of pRANK with the accuracy of a regular support vector machine (SVM) and the multiple
instance learning SVM (miSVM) of Andrews et al [33, 35]. pRANK outperforms the other
SVM-based methods with an AUC-ROC of 96.8%. Furthermore, both multiple instance classi-
fiers, miSVM and pRANK, perform better than a conventional SVM. This improvement in
accuracy clearly indicates the usefulness of employing multiple instance learning in this prob-
lem. The conventional SVM does not model the ambiguity and noise in the experimental
annotations, and is more affected by it than the MIL approaches. pRANK uses an ensemble of
predictors (see Methods section for details); therefore we also compared its performance with
Random Forests [36], which provided similar performance to the SVM classifier (see Table 2).
Fig 1. An illustration of the concept of multiple-instance learning. In MIL, training examples come in bags; a positive bag contains a set of examples,
with the constraint that at least one of them must be positive. In our setup a positive bag corresponds to an annotated prion domain, and this constraint
captures the inaccuracy that is inherent in experimentally delineating a prion-forming domain: the actual minimal domain that supports prion formation is
rarely fully characterized, and is typically embedded within the annotated domain. The examples in a negative bag are all negative (all the sequence
windows outside a prion-forming domain are negative examples).
https://doi.org/10.1371/journal.pcbi.1005465.g001
Amino acid composition predicts prion activity
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1005465 April 10, 2017 6 / 20
Other than an improvement in accuracy, pRANK offers several advantages over the
miSVM formulation. miSVM requires optimization over the labels of examples in positive
bags, making it a combinatorial optimization problem, which is solved using a heuristic
approach based on iterative retraining an SVM with labels imputed in each iteration. As a con-
sequence, miSVM may not converge to the optimal solution of the underlying mathematical
formulation. Furthermore, the iterative re-training of an SVM in miSVM makes it very time
consuming. Instead of constraints over labels, as in miSVM, the pRANK formulation involves
constraints over the discriminant value of the highest scoring example in a positive bag (see
Methods section). This is a more direct representation of the classification problem and leads
to a better solution through stochastic subgradient optimization. Furthermore, it is a simpler
model with fewer slack variables, which further contributes to the speed advantage of pRANK.
pRANK takes under two minutes to train on the whole yeast proteome using a single core on
an Intel i5 machine with 4GB of RAM whereas it was not feasible to run miSVM on this data-
set on the same computer due to memory limitations.
Evaluation over the yeast proteome
To compare the methods on a proteome-wide dataset we used all 22 known Q/N rich yeast
prion domains and a non-redundant set of 5,575 yeast proteins as positive/negative examples.
All proteins in the yeast proteome that were more than 90% similar to the known yeast prion
proteins were removed; among the remaining proteins we ensured a level of sequence similar-
ity of no more than 40%. In this analysis, we compared pRANK, PAPA, PrionW and two other
methods: the Michelitsh-Weissman (MW) score and the PLAAC-Log Likelihood Ratio (LLR)
[25]. The MW score is equal to the maximum number of Q or N residues in a sequence win-
dow with at least 80 amino acids. PLAAC-LLR is the HMM method used by Alberti et al., and
then updated using additional prion-like domains [25]. The scores for these algorithms were
obtained using the PLAAC webserver [25]. At the proteome level precision-recall curves are
more informative than ROC curves due to only a small number of expected prions in the pro-
teome. The PR curves in Fig 2 clearly show that pRANK outperforms all other methods at the
proteome level as well: its AUC-PR score is 53.3%, while the next best method (PLAAC-LLR)
has a score of 27.0%. We note that the score for PLAAC-LLR potentially overestimate its accu-
racy because some of the proteins in the yeast proteome have been used in training it. The
advantage of pRANK can also be observed in the sharp initial rise in the ROC curves in Fig 2
compared to the other methods.
To obtain insight on the predictions made by pRANK we performed a Gene Ontology
enrichment analysis using the GOrilla tool [37] on the ranking produced by pRANK (exclud-
ing all known yeast prions), and compared the enriched categories with those that we got for
the known yeast prions. Fourteen out of the 22 proteins that contain prion domains are anno-
tated as “nucleic acid binding”, with an FDR q-value of 0.04. This category is also highly signif-
icantly enriched in the top 200 predictions made by pRANK (FDR q-value of 4.28E-7). In fact,
the top enriched categories are all related to nucleic acid binding or transcription factor activ-
ity. At the bottom of the list we find a few other types of enriched categories such as “zinc ion
biding” with an FDR q-value of 3.18E-2 (see Tables B and C in S1 File for details).
Evaluation in other species
A number of human proteins contain prion-like domains that compositionally resemble yeast
prion domains. In recent years mutations in several of these have been linked to degenerative
disorders such as ALS and frontotemporal dementia [38, 39]. These proteins include TAF15,
EWSR1, hnRNPA1, FUS, hnRNPA2, TDP43, and TIA1. We evaluated the ability of pRANK
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and other methods to distinguish these seven proteins from a non-redundant set of 15,948
proteins not known to have prion-like activity (applying our non-redundancy filter to the
human prion-like proteins yielded a subset of five of them). The results reported in Table 3
again show the effectiveness of pRANK compared to the other methods. We note that human
prion-like proteins have somewhat different sequence characteristics than yeast prions, so the
weaker performance of PAPA for example, which was specifically designed for yeast prions, is
not surprising. The three top ranking proteins are associated with diseases characterized by
amyloid deposits: hnRNP-UL1, the top ranking protein by pRANK was recently shown to be
involved in amyotrophic lateral sclerosis (ALS) [40]; mutations in the PrD of our second pre-
diction, HNRPDL, causes limb-girdle muscular dystrophy [41]; the 3rd prediction,
TRNAU1AP, is also associated with ALS [42].
It was recently discovered that the Rho Termination Factor in Clostridium botulinum acts
as a prion [26]. It is the first bacterial prion discovered thus far, and was the top PAPA hit in
the Clostridium botulinum proteome. Using pRANK trained on yeast prions we found it is
ranked six out of 3678 proteins, and its prion domain was correctly identified.
Fig 2. Receiver operating characteristic curves (a) and precision-recall curves (b) for proteome-wide prediction in yeast. FPR and TPR are the
false and true positive rates. The numbers in parentheses represent the area under the curve. Notice that the x-axis of the ROC plot is trimmed at FPR of
5%. MW and PLAAC-LLR indicate the results for the Michelitsh-Weissman score and the HMM based algorithm presented in [25].
https://doi.org/10.1371/journal.pcbi.1005465.g002
Table 3. Classifier performance proteome wide. Performance is measured with leave-one-protein-out cross-validation using the area under the ROC curve
(AUC-ROC) and the area under the precision recall curve (AUC-PR).
Classifier yeast human
AUC-ROC AUC-PR AUC-ROC AUC-PR
pRANK 99.2 53.3 99.7 26.2
MW 99.2 22.4 96.5 1.10
PLAAC-LLR 99.2 27.0 99.7 5.20
PAPA 98.4 24.6 99.4 5.50
prionW 98.4 17.5 98.6 1.00
https://doi.org/10.1371/journal.pcbi.1005465.t003
Amino acid composition predicts prion activity
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pRANK performance in proteins with polyQ tracts. Since pRANK uses only amino acid
composition, proteins with certain compositional biases can potentially show up as false posi-
tives. A prime example consists of proteins that contain a polyQ tract. Our non-redundant
dataset of the yeast proteome contains 50 proteins with at least one occurrence of a polyQ tract
of length 10. Because of the high weight assigned by pRANK to Q (see Fig 3), these can receive
high scores from pRANK; however, the top 50 pRANK predictions contain only seven such
proteins, and the median rank of these 50 proteins is 169. And interestingly, it has been shown
Fig 3. Comparison of amino acid weights for different methods. (a) the weights for pRANK over the Alberti dataset; (b) the pRANK weights in
proteome wide evaluation; (c) shows the log-odds ratio, obtained by Angarica et al., of the frequencies of occurrence of different amino acids in prion
domains in the yeast prions relative to their corresponding background frequencies in the protein universe. Figure (d) shows the log-odds ratios obtained
experimentally by the random mutagenesis experiment by Toombs et al.
https://doi.org/10.1371/journal.pcbi.1005465.g003
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that a polyQ domain can lead to aggregation in the presence of the prion form of Rnq1 [43].
Finally, we note that such false positives can arise for any classifier that uses amino acid com-
position exclusively, and the results need to be interpreted with care.
Amino acid weights
To obtain an understanding of the importance of different amino acids for predicting prio-
genicity, we have plotted the weights assigned to individual amino acids by pRANK. These
weights are plotted separately for the evaluations over the Alberti and proteome-wide data
sets. For comparison, we have also plotted the log-odds ratios used in the methods by Angarica
et al. and Toombs et al. (see Fig 3). First we note the high positive weights of Q and N as
pRANK features in both pRANK evaluations. This correlates with the fact that all the prion
domains in the Alberti dataset are Q/N rich and is also supported by the reported importance
for these amino acids in the works by Angarica et al. and Sabate et al. These amino acids
receive only a slightly positive score in the PAPA method, as it was specifically designed to
answer a very different question, namely to predict how small compositional changes in a pro-
tein that resembles Sup35 affect its prion forming propensity. This observation also explains
the lower performance of PAPA at the proteome level compared to pRANK.
Next, we observe that the two evaluations of pRANK produced somewhat different residue
weights, which is a result of the fact that the task of priogenicity prediction in the Alberti data-
set and the detection of prion proteins in a proteome are two different problems. The differ-
ence is the result in the choice of negative examples: The negative examples in the Alberti
dataset are Q/N rich domains flagged by Alberti et al. as candidate prion domains, whereas
they are random non-prions in the proteome-wide evaluation protocol. We note that when
testing pRANK trained on Alberti negatives on a genome-wide test set we obtain an AUC-PR
score of 30%, which is much lower than pRANK accuracy when trained genome-wide. This
highlights the importance of choosing the negative examples to reflect the intended use of the
classifier, i.e., use a wide selection of negative examples when using pRANK for a genome-
wide screen.
We note a few differences between the log odds ratios reported by Angarica et al. and the
weights found in the pRANK genome-wide screen. Cysteine has the lowest negative weight
log-odds ratio, while its pRANK weight is close to zero. This unexpected difference has support
in experiments performed by Krishnan and Lindquist [44]. They introduced a cysteine at 32
different positions in Sup35, and showed that none of these mutations affected prion activity.
Another amino acid where a big difference is observed is tryptophan: it has the second lowest
negative log-odds value, but is assigned a weight that is close to zero in the genome-wide
pRANK evaluation. There is experimental support for the non-deleterious effect of tryptophan
on prion formation: MacLea et al. showed that replacing tyrosines in Sup35 with tryptophan
increases prion formation [45], and similar results were reported by Ohhashi et al. [46].
Although tryptophan is known to strongly promote aggregation, it has been suggested that it
too strongly promotes prion formation, and therefore is not well tolerated in disordered seg-
ments [22]; this observation is in agreement with the analysis of Buck et al. [47]. Finally, when
comparing the weights assigned by these methods with the residue propensities in protein-car-
bohydrate, protein-ligand, and protein-DNA binding sites computed by Malik and Ahmad
[48], no obvious patterns emerge; the interested reader is referred to Fig 2 in that paper.
In-silico mutation analysis
Paul et al. recently conducted a targeted mutation analysis of four prion-like domains from the
Alberti dataset that had no detectable prion activity [32]. Four to seven prion inhibiting amino
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acids in each domain were replaced with either neutral or prion-promoting residues to
increase the PAPA scores of the prion domain. These rationally-designed mutations led to the
emergence of prion activity in two out of the four prion-like domains from Puf4 and
YLR177W when inserted in place of the Sup35 prion domain. A third, from Pdc2, exhibited in
vivo aggregation, and appeared to form unstable prions. The fourth, Yck1, formed in vivo
aggregates but could not be tested in the prion activity assay. We performed an analogous
experiment in silico with the aim of seeing how closely the scores of pRANK and PrionW cap-
ture these experimental findings. The results in Table 4 show that the scores of all the methods
(pRANK, PAPA and PrionW) for the mutated proteins are higher than their wild-type ver-
sions (this is so for PAPA by construction). In order to classify a protein as a prion we selected
a threshold score for each method. For PAPA and pRANK, this threshold is the score of the
highest scoring non-prion in the Alberti dataset. For PrionW, the default score of 73.55 is
used. At these threshold values, pRANK is able to correctly identify the formation of prions
due to mutations for three out of the four proteins. Although Pdc2mut only formed unstable
prions, all three methods scored it as prion-positive. In conclusion, pRANK scores show the
highest agreement with the experimental findings of Paul et al. in comparison to both PAPA
and PrionW.
The drivers of prion activity
The fact that we can very accurately predict prion formation based solely on amino acid
composition is not contradictory to the idea that primary sequence and local regions have a
role in determining prion activity. There are three basic explanations that could explain our
result: 1) Local regions and primary sequence elements are not important, and only compo-
sition matters; 2) local regions and primary sequence elements are important, but the
sequence requirements for these are sufficiently flexible that these elements will turn up by
chance in any sequence of proper composition, and thus, their presence has little predictive
value; or 3) local sequence elements do play a role in the process, but these elements can
only create prions when embedded in the proper compositional context, so overall composi-
tion ends up being a more dominant factor in prediction. It is important to note that we are
not arguing for the first option, and we believe that some combination of (2) and (3) holds
true.
As an example, consider steric zippers predicted by ZipperDB [49]. The presence of pre-
dicted zipper segments has no predictive value for the Alberti dataset, since every single one of
these proteins has predicted zipper segments [50]. So, it is entirely possible that zipper seg-
ments are necessary for prion formation and act as key nucleating sites, but because such seg-
ments are present in every prion-like domain, it is not necessary to consider them when
making predictions. This idea is also strongly supported by experimental data. Deletion
Table 4. Results of mutation analysis. Scores in bold correspond to correct predictions by a method at the given threshold value. The highest score of a
non-prion in the Alberti dataset is chosen as the threshold for PAPA and pRANK whereas for PrionW, the value suggested in their paper has been used. No
prion like domain was found by PrionW in YLR177W and YLR177mut.
Protein Effect of mutation pRANK PAPA PrionW
WT mutant WT mutant WT mutant
Puf4 prion formation -0.49 0.70 0 0.10 73.85 74.26
YLR177W prion formation -1.98 2.04 -0.02 0.11 * *
Yck1 aggregation -4.44 -1.74 -0.09 0.11 64.05 82.69
Pdc2 unstable prions 0.12 2.10 -0.02 0.10 68.65 77.18
threshold: 0.2 0.09 73.55
https://doi.org/10.1371/journal.pcbi.1005465.t004
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analysis of scrambled versions of Sup35 [22] and Ure2 [10] show that these domains each con-
tain multiple distinct segments capable of nucleating prion formation, suggesting that nucleat-
ing sites will commonly occur by chance in domains with prion-like composition. Likewise,
recent analysis of the prion domains of Sup35, Mot3, Swi1, and Ure2 identified pWALTZ seg-
ments in each protein that are capable of nucleating prion formation [51]. However, for Sup35
[52] and Swi1 [53], the identified pWALTZ segments are dispensable for prion nucleation.
This suggests that, consistent with previous analysis of Sup35 [54], multiple distinct sites in
these proteins can act as nucleating elements.
Another point we would like to make is that the fact that many point mutations cause path-
ological phenotypes is not in contradiction to our results. If a protein has an aggregation pro-
pensity that is near the threshold for aggregation, it would be expected that many different
point mutations could push the protein over the edge, whether aggregation is driven by short
stretches or overall composition. Indeed, we have shown that we can predict the effects of
many such mutations in prion-like domains solely based on composition [32, 55].
Methods
Data and pre-processing
We have utilized two different datasets for this work as discussed below.
The Alberti dataset. The dataset generated by Alberti et al. is used as the basis for evaluat-
ing our classifiers [7]. This dataset contains 100 proteins that were tested experimentally for
prion formation using four assays. A total of 18 proteins passed all four assays and are taken as
the prion (positive) set. The prion domain in these 18 proteins was also localized by Alberti
et al. However, no effort was made to localize the minimal fragment in these proteins that sup-
ports prion formation. Eighteen proteins failed all four assays and are taken as the non-prion
(negative) set. Other than these 36 proteins, the remaining 64 proteins either showed varying
levels of activities in the assays or could not be experimentally tested. Three of these proteins
(Cyc8, Mot3 and Nup100) were shown elsewhere to support prion formation in their native
contexts together with another protein, SFP1, which was not tested by Alberti et al. [56]. We
use these four prions together with the 18 found by Alberti et al. in our analysis. We have veri-
fied that the dataset is non-redundant at the 40% sequence identity level using CD-HIT [57]
by checking that no cluster contains more than positive example (prion-forming) or more
than one negative example (non prion-forming). CD-HIT was run using the command line
arguments -c 0.4 -n 2 -g 1. Furthermore, we also verified that the prion-forming domains
are non-redundant at the 50% sequence identity level.
Proteome-wide datasets. In order to compare the methods at the proteome level, we cre-
ated a non-redundant set of S. cerevisiae and human proteins. For the positive examples in
yeast we used the same set of non-redundant yeast prion proteins described above; for the
human dataset we used a set of seven known human prion-like proteins (TAF15, EWSR1,
hnRNPA1, FUS, hnRNPA2, TDP43, and TIA1) [39]. For the construction of a non-redundant
negative set, all proteins with more than 90% sequence identity to known prions were
removed. The remaining proteins were then clustered based on their sequence identity using
CD-HIT such that no two sequences within a cluster have more than 40% sequence identity
[57]. The representative sequences of the clusters reported by CD-HIT were then used as the
non-redundant negative set containing 5,575 proteins in yeast, and 15,948 in human. CD-HIT
was used with the same command line as above. Non-redundancy filtering yielded five human
prion-like proteins (TAF15, EWSR1, hnRNPA1, TDP43, and TIA1). Very few proteins were
removed as being too similar to the positive examples. For example, in the yeast data, we
started with 6,528 proteins; the first stage of filtering on the basis of similarity to yeast prions
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left us with 6,506 proteins, and the second step of creating a non-redundant set at the 40%
sequence identity level yielded 5,575 proteins.
Evaluation protocols
We evaluate our classifiers on the Alberti dataset to explore their specificity in detecting prio-
genicity in proteins that are Q/N rich and proteome-wide to determine the accuracy of prote-
ome wide searches. All the methods we evaluated assign a score to a sequence window that
reflects its priogenicity; scores are assigned at the protein level by computing the maximum
score over all sequence windows within the protein.
Evaluation on the Alberti dataset. Evalution on the Alberti dataset was performed using
a leave-one-protein-out cross-validation protocol. For this purpose, we defined a positive
training set composed of 22 domains including the 18 prion-like domains that passed all four
Albert et al. assays and four other known yeast prions (Cyc8, Sfp1, Mot3, and Nup100). The
negative set consists of the 18 proteins that failed all four assays. In this protocol, a single pro-
tein is held-out while the classifier is trained over the set of remaining proteins. Testing is per-
formed on the held-out protein. This process is repeated for each protein followed by
calculation of the performance metrics described below.
Proteome-wide evaluation. We performed a proteome-wide evaluation using a bootstrap
protocol as described next. For a given proteome, the set of positive examples is defined as the
set of all known prion proteins in that proteome and the set of negative examples is the set of
all non-redundant proteins in that proteome that are not known to have prion activity. In this
protocol a prion protein is held-out while the classifier is trained on the remaining prions and
a randomly selected subset of the negative proteins. The classifier is then tested on the held-
out prion and the rest of the negative examples that have not been used in training. This is
repeated over all prion proteins, giving classification results for all prions and a random set of
negative examples. This procedure is repeated a number of times to construct an averaged
ROC curve for each proteome. The ensemble of classifiers is then used to generate the predic-
tions for a given proteome, where for a given protein only classifiers where that example has
not participated as a negative example are used.
Prediction quality metrics
In order to assess the quality of predictions, we use the following metrics:
• Area under the Receiver Operating Characteristic Curve (AUC-ROC). The Receiver Operat-
ing Characteristic (ROC) curve for a classifier is obtained through cross-validation or boot-
strapping using a labeled dataset of prion and non-prion proteins. It is a plot of the true posi-
tive rate vs. the false positive rate for varying thresholds on the classification scores.
• Area under the Precision-Recall Curve (AUC-PR). For proteome level evaluation, where the
number of negative examples is very large in comparison to the true positives, ROC curves
are less informative. Therefore we also used Precision-Recall (PR) curves. A PR-curve is a
plot of precision against recall for varying thresholds of the classification score. The area
under the PR-curve (AUC-PR) is equal to 100% for an ideal classifier.
Classifiers
Classification of whether a given residue of a protein is within a prion domain or not is per-
formed on the basis of features derived from residues in a sequence window centered at that
residue (see Fig 4). Next, we introduce some notation used in describing our methods. We
consider a labeled dataset consisting of N training examples {(xi, yi)|i = 1, . . ., N}, where xi is
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the feature representation of the sequence window centered at a given residue and yi 2
{+1, −1} is its associated label indicating whether the central residue of that window lies in an
annotated prion domain or not. We denote by P the set of all prion proteins in the training
set, and by N , the set of non-prion proteins in the training set. For a prion protein p 2 P, we
denote the set of fixed-size sequence windows in its annotated prion domain by D+(p) and the
rest as D−(p). For a non-prion protein, all windows are labeled negative. The set of all negative
examples, N win is defined as the collection of all sequence windows from all non-prion pro-
teins together with the non-prion domain regions from prion proteins. Similarly, we denote
the collection of all known positive examples from the prion domains of all prion proteins as
Pwin. This training data is used to train a classifier which can be used to score the priogenicity
of a sequence window. The maximum scoring window in a protein is used for prion classifica-
tion. We have considered the following classifiers in this work.
pWALTZ-like scoring. To evaluate whether pWALTZ accuracy is the result of primary
sequence information we re-implemented the aspect of the method that uses hexamers that
promote/inhibit amyloid fiber formation. A multiple sequence alignment of all those hexam-
ers was constructed, and for each column in the alignment we computed the log-odds ratio
of each residue in the two groups of amyloid promoting/inhibiting. To remove primary
sequence dependency of the method we either scrambled the positions of the PSSM (equiva-
lent to scrambling the columns of the multiple sequence alignment), or scrambled the hex-
amers that make up the alignment. When scrambling the hexamers, we considered 100
different permutations. A final experiment considered scrambled versions of the annotated
prion domain in training/testing; for this experiment 100 permutations of each domain
were used. Our implementation of pWALTZ is provided as part of the software package
associated with this publication.
Support vector machines. As a baseline classifier, we used a linear SVM, which is com-
monly used in bioinformatics [35]. The SVM uses all examples in Pwin as positive examples
and all examples in N win as negative examples. For training and evaluation of the SVM, we
used the PyML package [35]. The margin violation parameter for the SVM (C) was coarsely
optimized through cross-validation; class-specific values of C inversely proportional to class
size were used to address class imbalance, which is the default behavior of PyML.
Fig 4. Prion prediction as a classification problem. Sequence windows within the protein are denoted by double arrows. Sequence windows within the
prion-forming domain (highlighted as a red box), are in red; sequence windows that do not overlap the annotated domain are shown in grey; those are
used as negative examples.
https://doi.org/10.1371/journal.pcbi.1005465.g004
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Multiple instance SVM. Multiple instance learning [33] is a supervised learning frame-
work where examples come in bags, either positive or negative. As described earlier, in a pos-
itive bag (a prion-forming domain) it is assumed that at least one example in the bag is
indeed positive; in a negative bag all examples are negative (see Fig 1). This is a weaker form
of labeling positive examples which captures very well the scenario in this classification prob-
lem, where not all of the sequence windows within a bag are prionogenic. This allows the
classifier to essentially ignore the windows within a bag that do not represent the target con-
cept well. Moreover, it allows us to learn from prion proteins for which domain annotations
are unavailable. This can be done by taking D+ (p) to be the whole protein and D− (p) = Ø for
such cases. In our problem, we model the examples in an annotated prion domain D+ (p) for
p 2 P as a single positive bag. The multiple instance SVM (miSVM) is an MIL formulation
based on support vector machine that is defined as follows [33]:
min
y2   1;þ1f gN
min
w;r;ξ0
1
2
wTw þ
C
N
XN
i¼1
xi
 !
subject to :
yi wTxi þ rð Þ  1   xi; 8i
X
i2Dþ pð Þ
yi þ 1
2
 1; 8p 2 P
yi ¼   1;8i 2 N win:
ð1Þ
In this formulation, the objective is to find the optimal labeling of the examples that com-
prise the positive bags such that at least one example in each positive bag is labeled as posi-
tive. This is mathematically represented by the constraint
P
i2Dþ pð Þ
yiþ1
2
 1. The other
constraints ensure correct labeling of the given training examples, and that all negative
examples are labeled as negative. In our context, this means that a trained miSVM will
choose at least one positive example in every annotated prion domain. All the sequence win-
dows from the rest of the prion protein and from non-prion proteins are taken as negative
examples. The miSVM formulation is a combinatorial optimization problem. We use the
heuristic algorithm proposed by Andrews et al. [33] for its solution through PyML.
pRANK. In pRANK we aim to find a weight vector w that provides a large margin
between the score of the most prion-like window in an annotated prion domain and the score
of the highest scoring negative example:
min
w;ξ
l
2
wTw þ
1
j P j
X
p2P
xp
 !
subject to :
max
i2Dþ pð Þ
wTxið Þ  max
j2Nwin
wTxj
 
þ 1   xp 8p 2 P
xp  0 8p 2 P:
ð2Þ
This formulation has several advantages over the miSVM formulation. miSVM requires
optimization over the labels of examples in positive bags, making it a combinatorial optimiza-
tion problem, which is solved in practice using heuristic approaches. Our formulation replaces
constraints over the labels with constraints over the discriminant value of the highest scoring
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example in a positive bag, which is a more direct representation of the task, and lends itself to
more effective optimization strategies. Furthermore, it is a simpler model with fewer slack vari-
ables, which further contributes to the speed advantage of pRANK.
To solve the pRANK constrained optimization problem presented above we proceed as fol-
lows. For a given w, we define xp and xN to be the highest scoring example in D+ (p) and Nwin,
respectively. We can then write the hinge loss corresponding to the above formulation for
prion protein p as l(p; w) = max{0, 1 − (wTxp −wTxN)}. Based on this definition of the loss func-
tion, we propose an approximate method inspired by the sub-gradient solver Pegasos [58]. Fol-
lowing the approach taken in the Pegasos paper, we first express the pRANK formulation as an
unconstrained optimization problem:
min
w
l
2
wTw þ
1
j P j
X
p2P
l p;wð Þ
 !
: ð3Þ
We then optimize this objective function using stochastic sub-gradient optimization. We
start with a zero weight vector and at iteration t of the algorithm, we choose a random protein
pt and take a step in the direction of the sub-gradient of the objective function using the sub-
gradient computed on the basis of pt, i.e., we consider
gðpt;wÞ ¼
l
2
wTw þ l pt;wð Þ; ð4Þ
whose sub-gradient is given by:
g 0ðpt;wtÞ ¼ lwt   1 wTt x
p < 1þ wTt x
N
 
xp   xNð Þ: ð5Þ
Here 1 ½  is the indicator function which is equal to one if its argument is true (i.e., there is a
margin violation) and zero otherwise, and xp and xN are the the highest scoring positive exam-
ples from the positive and negative bags, respectively. We then update the weight vector as
wt+1 wt − ηt g0(pt; wt) using a step size of Zt ¼ 1lt. The algorithm is stopped after a pre-deter-
mined number of iterations and the final weight vector is used for classification. Note that, at
each iteration, xp and xN can change. Together with the randomness in the order of proteins,
the selection of xp and xN can cause different runs of the algorithm to converge to different
weight vectors. In order to limit this effect, we combine the outputs of an ensemble of 10 classi-
fiers to produce the final prediction. The output of each classifier in the ensemble is first nor-
malized to have the same range and then the average value of the prediction scores from
different classifiers is taken as the final prediction score. An implementation of pRANK is pro-
vided as part of the software package associated with this publication.
Feature representation. As discussed above, our training examples are fixed-size win-
dows; each window was represented by its amino acid composition: a vector of counts of how
many times each amino acid occurs within a sequence window. In the context of SVM classifi-
ers it is also known as the 1-spectrum feature representation [59]. Following Toombs et al.
[50], we used 41 as the window size.
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